Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide in Patients With Psoriasis and Obesity
NCT06937060Phase 3Recruiting
- Sponsor
- The University of Hong Kong
- Start
- Mar 2025
- Primary completion
- Jul 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of semaglutide in psoriasis, sponsored by The University of Hong Kong. Started Mar 2025; status: recruiting.
02
Drugs
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT06937060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06937060.